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Summary
PRINCIPLES: Switzerland is divided into 26 cantons of
variable population size and cultural characteristics. Al-
though a federal law to protect against passive smoking
and a national tobacco control programme exist, details
of tobacco-related policies are canton-specific. This study
aimed to project gender-specific tobacco-related cancer
mortality in Switzerland at different geographical levels for
the periods 2009–2013 and 2014–2018.
METHODS: In this analysis, data on Swiss tobacco-related
cancer mortality from 1984 until 2008 were used. Bayesian
age-period-cohort models were formulated to assess past
trends of gender-specific tobacco-related cancer mortality
and to project them up to 2018 at cantonal and language
region levels. Furthermore, estimates are provided on a na-
tional scale by age categories of 50–69 and ≥70 years.
RESULTS: Model-based estimates at cantonal level iden-
tified regions with low and high tobacco-related cancer
mortality rates for the observed and projected periods. Our
analysis based on language regions showed the lowest mor-
tality in the German-speaking part. Projections at national
level, between younger (age 50–69) and older (age ≥70)
males, indicated an ongoing decreasing trend for males but
an upward trend for females. The gap in tobacco-related
cancer mortality rates between younger and older males
seems to be shrinking. In females, a stronger rise was ob-
tained for the younger age group.
CONCLUSION: Our findings indicate region-, sex- and
age-related differences in tobacco-related cancer mortality
in Switzerland and this could be useful for healthcare plan-
ning and for evaluating the impact of canton-specific
tobacco-related policies and interventions.
Key words: age-period-cohort models; tobacco-related
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Introduction
Tobacco-smoking is a major cause of premature mortality.
In 1990, around three-quarters of a million deaths in the
age group 35–69 years were attributable to tobacco
smoking in Europe [1]. In fact, smoking accounts for more
deaths than traffic-accidents, acquired immunodeficiency
syndrome (AIDS), alcohol, cocaine, homicide, suicide and
fires together [2]. Smoking cessation reduces the hazard
substantially in the younger age group [3]. Smoking beha-
viour has changed over the last decades. In Switzerland,
smoking prevalence decreased during 1992 and 2007 in
both genders [4]. Several factors may have contributed to
this trend, including prevention programmes and greater
sensitivity to mortality from tobacco-related illness in
males [5]. Smoking can be supposedly used to balance
stress and younger women especially use smoking to con-
trol or even suppress appetite. On average, the weight of
smokers is 3–4 kg lower than for nonsmokers [6].
Figure 1
Canton-specific smoking ban regulations indicating application of
the federal law (”Bundesgesetz zum Schutz vor Passivrauchen”) (in
grey), further regulations covering service in smoke-rooms (in
yellow) and no service in smoke-rooms (in green).
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Reports from the International Agency for Research on
Cancer showed that in 2008 21.9% of all male cancer
deaths in Switzerland were related to the lung, whereas the
proportion was 12.7% for Swiss women. Smoking is the
major risk factor for the development of lung cancer, but
it also causes cancers at other sites. Smoking may have an
effect on cancers of the larynx and the pharynx [7]. Par-
ental smoking may induce childhood cancer, but studies
showing evidence of a definite association are still lack-
ing. In addition, there is strong evidence of a causal as-
sociation between passive smoking and lung cancer [8].
Doll and Peto [9] considered the following cancer sites to
be related to tobacco: lung (C33–C34), oesophagus (C15),
rectum (C20), pancreas (C25), bladder (C67) and cancer of
other respiratory sites (C00–C14) including cancer of the
lip, tongue, mouth, larynx, trachea and pharynx (excluding
nasopharynx).
Switzerland is divided into 26 cantons, which vary in pop-
ulation size and cultural characteristics. Regulations, for
example in health systems, are canton-specific, covering
domains which are not controlled by the federal consti-
tution. In 2010 a federal law to protect against passive
smoking was enacted, aiming at smoke-free interiors in
enclosed spaces that are publicly accessible (i.e. restaur-
ants, bars, schools, hospitals etc.), and workplaces with two
or more people. However, smoking-rooms still exist un-
der certain conditions in many cantons as federal law just
provides the minimum provisions for protection against
passive smoking and stricter smoking-related laws are
canton-dependent. Figure 1 shows the Swiss cantons ac-
cording to their smoking ban regulations in restaurants in
May 2012. All cantons applied the national law, which can
be seen as a minimal protection against passive smoking,
and some defined further regulations. These refinements
either allow service only in those rooms indicated for
smoking (‘smoke-rooms’) or prohibit any service in
smoke-rooms.
Information about the trend of tobacco-related cancer mor-
tality over time, as well as the spatial distribution of the
disease, are essential for healthcare planning related to
smoking behaviour. This can identify areas with high
tobacco-specific cancer mortality. Projections of mortality
rates are helpful tools for assessing the future burden of a
disease and as a basis for evaluating the impact of interven-
tions carried out. Model-based estimates can then be com-
pared with observed data for the projection periods.
Age-period-cohort (APC) models are commonly used to
project cancer mortality and incidence. With this approach,
the dataset is stratified into three components separating
age, the period when the event occurred and the birth co-
hort of the person. Typically, projections based on APC
models are done at country level [10, 11]; however, estim-
ates at subunits may be useful [12] especially when health-
care planning is decentralised as in the case of Switzerland.
This study aimed to project gender-specific tobacco-related
cancer mortality in Switzerland at different geographical
levels for the periods 2009–2013 and 2014–2018. Projected
estimates at a cantonal level may identify high- or low-
risk areas and help evaluate canton-specific smoking-re-
lated policies in the future. In addition, mortality data were
aggregated over the three language regions (i.e. German,
French and Italian) to assess trends among the regions
which can be compared with trends in same language
neighbouring countries – Germany, France and Italy. Fur-
thermore, countrywide projections were estimated for spe-
cific age groups to determine the burden of tobacco-related
cancer in the future on a larger scale and possibly identify
age-specific differences.
Methods
Data sources and management
Mortality data at an individual level were provided by
the Swiss Federal Statistical Office (FSO). Cancer death
counts related to tobacco, following the definition by Doll
and Peto [9], were used for the analysis. Tobacco-related
cancer rarely occurs in persons younger than 50 years.
Therefore, we excluded death counts of those of younger
age. In 1995, priority given to certain causes of deaths was
removed from rules related to coding death certificates.
This change affected cause-specific reported deaths, but the
FSO provides disease-related correction factors to adjust
for the years before 1995 [13]. Estimated rates were (age)
standardised directly, using Segi World population [14].
Subgroup-specific population data at a cantonal level were
obtained from the webpage of the FSO, covering the five
5-year time periods 1984–1988 to 2004–2008, as well as
2009–2013 and 2014–2018. The data for the latter time
periods were estimated by the FSO assuming a mid-way
scenario, based on past population trends and assuming no
extreme changes (e.g. migration). Age and period were ag-
gregated into five-year groups.
Cantons with a small number of cases, which did not allow
for reliable estimates, were merged with their neighbours.
These included canton Uri, Obwalden and Nidwalden, as
well as Appenzell Ausserrhoden and Appenzell Innerr-
hoden. A map of Switzerland, as well as the cantonal ab-
breviations, are provided in Appendix A. ArcGIS, a geo-
graphic information system, was used to create maps il-
lustrating the results. The required shapefile describing the
Figure 2
Overall lung and all tobacco-related cancer deaths observed during
1984–2008 at the national level for males and females.
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spatial configuration of the cantons was obtained from the
FSO and modified.
Statistical analysis
Bayesian Poisson and Negative Binomial APC regression
models were formulated and fitted in WinBUGS (Imperial
College and MRC, London, UK) using Markov chain
Monte Carlo (MCMC) simulations. The mean of the age-
and period-specific death counts μij was regressed on the
effects of age, period and cohort. The general model ap-
plied for projecting at cantonal level reads as follows:
where nijk is the population for the age group (i), period (j)
and region (k), α, β and γ account for the effect of age, peri-
od and cohort, respectively. Canton-specific random effects
φk modelled via conditional autoregressive (CAR) specific-
ations [15] were included to allow for spatial correlation.
Bayesian APC-models were applied to project age- and
gender-specific tobacco-related cancer mortality for the
periods 2009–2013 and 2014–2018 (1.) at a national level,
(2.) for the three language regions, and (3.) at cantonal
level. The models for countrywide and language-specific
analyses did not consider spatial random effects. Results
are presented for each gender and sub-region. In addition,
countrywide estimates are given for the age categories
50–69 and ≥70 years. The predictive performance of the
models was assessed by comparing model-based and ob-
served data using the sum of squared residuals. In partic-
ular, models were fitted during 1984–1998 and predictions
were obtained for the remaining period of 1999–2008. Im-
plementation details and model evaluation can be found in
Appendix B.
Results
Preliminary analysis suggested similar trends in lung and
tobacco-related cancer mortality in Switzerland during
1984 to 2008 (fig. 2). Death counts for males were stable,
while for females they increased steadily.
Age- and gender-specific projections at national level
Figure 3 shows observed and predicted tobacco-related
cancer mortality rates during 1984–2008 and 2009–2018,
respectively, for each gender and age category. For both
males and females, higher rates were observed for the
younger age group.
For males, a decreasing trend was seen which was less pro-
nounced from 1994–1998 onwards. On the other hand, pro-
jected absolute death counts increased during 2009–2013
and 2014–2018 (table 1), reflecting the demographic aging
of the population (fig. 4).
The difference in mortality rates between younger and
older males narrowed during the study periods. Overall, the
mortality rate in males decreased by approximately 30%.
Tobacco-related cancer mortality for Swiss women steadily
increased during the study period. In contrast to males,
model-based estimates indicated that the difference of mor-
tality rates between younger and older females increased.
The projected rates in 2014–2018 indicate that the female
tobacco-related cancer mortality rates rose by more than
60% during the whole study period.
Gender-specific projections for the language regions
Figure 5 shows the trends for gender-specific tobacco-re-
lated cancer mortality rates by language region. For males,
the lowest rates were observed for the German-speaking
region. No significant differences were observed for the
rates in the French- and Italian-speaking part for either sex.
Considering cause-specific mortality rates for females, the
gap between the lowest (German-speaking) and the highest
(French-speaking) region-specific rates clearly decreased
during the 30 study years. The German-speaking region did
show significantly lower rates up to 2008, but estimates
for the projected periods indicate no significant differen-
ce between the two regions. In 1984–1988 the rates for the
Italian-speaking area were not significantly different from
those in the German-speaking one. Subsequently, however,
a significantly higher tobacco-related cancer mortality rate
Figure 3
Age-specific and overall age-standardised tobacco-related cancer
mortality rates (per 100,000), observed (during 1984–2008) and
predicted (posterior median during 2009–2013 and 2014–2018) at
the national level for (a) males and (b) females. The vertical line
indicates the start of the prediction period.
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for females was observed in the Italian-speaking part.
Again, this can not be said for the projected periods.
Gender-specific projections at cantonal level
Figures 6 and 7 show the observed gender-specific (male
and female, respectively) tobacco-related cancer mortality
(age ≥50) observed for period 5 (2004–2008) and the
model-based projections for period 6 (2009–2013) and 7
(2014–2018) at cantonal level. Cantonal boundaries corres-
pond to the updated structure including merged cantons.
For males, an overall decreasing trend was observed,
whereas rates in the French-speaking cantons still remained
the highest, with the highest rates in the cantons of Valais
and Neuchâtel.
Lowest tobacco-related cancer mortality rates were ob-
served in the region covering the two cantons Appenzell
Ausserrhoden and Appenzell Innerrhoden in Eastern
Switzerland. Figure A2 (Appendix A) shows less precise
estimates for these regions. However, maps of the observed
rates (fig. 6(a), fig. 7(a)) confirm low rates.
For males, the highest decrease was observed for the two
cantons Zurich and Luzern – a steady reduction of around
12%–16% per period. For females, tobacco-related cancer
mortality was projected to remain stable in the cantons
Geneva and Graubünden. Furthermore, an increase of ap-
proximately 50% from 2004–2008 to 2014–2018 was es-
timated for the cantons Schaffhausen, Zug and Schwyz.
Figure 4
Relative change in population (in % based on preceding year) for
males (red) and females (blue) and age groups 50–69 (dashed)
and ≥70 years.
Discussion
This is the first study in Switzerland to project age- and
gender-specific tobacco-related cancer mortality at differ-
ent geographical levels for 2009–2013 and 2014–2018.
Gender-specific estimates of age-standardised rates are
presented for each canton and language region. In addition,
Figure 5
Language-region‒specific age-standardised tobacco-related cancer
mortality rates (per 100,000), observed (during 1984–2008) and
predicted (posterior median during 2009–2013 and 2014–2018) for
(a) males and (b) females. The vertical line indicates the start of the
prediction period.
Table 1: Raw age- and gender-specific tobacco-related cancer death counts observed (during 2004–2008) and projected (posterior median during 2009–2013 and
2014–2018) at country level. The numbers in the brackets correspond to 95% credible intervals.
2004–2008 2009–2013 2014–2018
Males
Overall 17,656 18,340 (17,300‒19 820) 19,270 (17,260‒22,100)
50–69 years 7,703 8,030 (7,522‒8,690) 8,023 (7,085‒9,333)
≥70 years 9,953 10,310 (9,713‒11,130) 11,260 (10,080‒12,910)
Females
Overall 9,349 11,080 (10,510‒11,620) 13,270 (11,960‒14,570)
50–69 years 3,453 4,255 (4,005‒4,534) 5,010 (4,416‒5,643)
≥70 years 5,896 6,824 (6,456‒7,148) 8,261 (7,453‒9,026)
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projections were also made on the national scale by the two
age categories 50–69 and ≥70 years.
Random effects at cantonal level were considered to ac-
count for the spatial correlation in mortality which arises
from similar exposures (e.g. environmental factors, cultural
characteristics, health policies) in neighbouring areas. The
models were formulated within the Bayesian framework of
inference, with CAR priors adopted for the random effects.
The Bayesian approach enables computation via the use of
MCMC and smooths the rates so that estimates from areas
with small populations do not dominate [16].
Overall, tobacco-related cancer mortality rates in males
are decreasing, whereas female mortality is increasing. Es-
timates at the national level show that mortality rates for
younger (age 50–69) females increased more than the rates
for older (age ≥70) ones. On the other hand, a steeper
downward trend was seen for young males than for older
ones. The less pronounced trend for males observed from
1994 onwards might be due to the change in death certific-
ate coding introduced in 1995. Early Swiss cancer mortal-
ity projections on the national scale estimated a plateau of
Figure 6
Age-standardised tobacco-related cancer mortality rates (per
100,000) for males age ≥50 years, (a) observed during 2004–2008
and predicted posterior median (b) during 2009–2013 and (c)
2014–2018.
Figure 7
Age-standardised tobacco-related cancer mortality rates (per
100,000) for females age ≥50years, (a) observed during
2004–2008 and predicted posterior median (b) during 2009–2013
and (c) 2014–2018.
male lung cancer mortality and a rising trend for females
for the end of the last century [17].
Maps of the projected rates can greatly help in identifying
cantons with high or low mortality rates. However, the ac-
curacy of estimates needs to be considered carefully. In this
study some cantons were merged to allow for more precise
estimates. Figure A2 (Appendix A) shows that estimates
for these regions have the lowest accuracy; however, they
seem reasonable compared to the trends of preceding peri-
ods and neighbouring cantons.
Important differences in cancer-related mortality between
the language regions were estimated for the observed, but
not the projected, periods. The latter may be explained by
the wide Bayesian credible intervals of the estimates. Res-
ults for language regions could be compared with projec-
tions in Germany, France and Italy to assess the hypothesis
that Swiss language regions reflect the situation in the cor-
responding neighbouring countries.
When comparing figure 1 with figures 6 and 7, it is inter-
esting to note that the highest rates occurred in the French-
speaking part, which applied the strictest smoking ban reg-
ulations. For males’ tobacco-related cancer mortality rates
in 2014–2018 (fig. 6(c)), cantons with the lowest rates in
the middle of the country resemble those only applying
minimal smoking-ban regulations (i.e. the federal law).
However, this finding may have arisen by chance because
it does not take into account the time lag of 20–30 years
between smoking (exposure) and disease/death.
In this study, cancer deaths below the age of 50 were ex-
cluded, as lung cancer in this age group is rarely due to to-
bacco smoking.
A decreasing prevalence of smoking in Switzerland has
been reported for 1992–2007 [4]. Marques-Vidal et al. re-
ported a stronger trend, corresponding with stage 4 of the
smoking epidemic model proposed by Lopez et al. [18].
This model describes different stages that indicate changes
in prevalence of smoking, tobacco consumption and mor-
tality due to smoking. Stage 4 is characterised by an overall
declining trend in smoking prevalence and a peak in male
smoking-related mortality. As a consequence of rapid
changes in female smoking behaviour during the mid-
twentieth century, mortality for women has increased.
However, a peak in female tobacco-related cancer mor-
tality has not yet been observed. These findings confirm
European trends in gender-specific lung cancer mortality.
Based on observations in 2007, rates in Europe were es-
timated to decrease for males and increase for females in
2012, which is consistent with our results [19]. However
studies in the United States showed a declining trend in fe-
male lung cancer mortality rates [20].
It should be noted that we only account for cancer mortality
and did not capture overall mortality due to smoking. Fur-
thermore, we did not account for smoking behaviour and
related changes over time. Model predictions could be op-
timised by using additional information. For example, Held
et al. [12] introduced information on tobacco consumption
into their analysis, estimated from numbers of cigarette
packages sold, to project lung cancer mortality in Western
Germany based on the effects of age and cohort. In
Switzerland, obtaining temporal as well as spatial inform-
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ation on smoking patterns remains a challenge, especially
for earlier years.
The current analysis cannot take into account the impact of
recent interventions, such as the Swiss federal law which
was introduced in 2010, because there are no mortality data
to estimate the intervention effect. This may be considered
as a limitation; however, our analysis will allow the assess-
ment of the impact of the smoking ban by comparing our
projections with the observed rates in the future.
Demographic changes have an impact on incidence and
mortality, especially for diseases mainly occurring in eld-
erly people, as the fraction of older people in the population
is rising. Among others, improved healthcare is one reason
for the increasing longevity.
Stable rates may be estimated despite the fact that the abso-
lute number of deaths is increasing because the elderly pop-
ulation is increasing. In this study, a downward trend was
observed for male cause-specific cancer mortality rates, al-
though raw death counts increased for these periods.
Maps of observed and projected tobacco-related cancer
mortality highlighted cantons with low or high rates. Es-
timates for language regions showed lowest mortality in
the German-speaking part of the country but appeared to
become less pronounced over time especially for women.
Countrywide projections indicated an ongoing declining
trend for males, while for females a continuing rise was
predicted, which is more pronounced in the younger age
group.
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Figures (large format)
Figure 1
Canton-specific smoking ban regulations indicating application of the federal law (”Bundesgesetz zum Schutz vor Passivrauchen”) (in grey),
further regulations covering service in smoke-rooms (in yellow) and no service in smoke-rooms (in green).
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Figure 2
Overall lung and all tobacco-related cancer deaths observed during 1984–2008 at the national level for males and females.
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Figure 3
Age-specific and overall age-standardised tobacco-related cancer mortality rates (per 100,000), observed (during 1984–2008) and predicted
(posterior median during 2009–2013 and 2014–2018) at the national level for (a) males and (b) females. The vertical line indicates the start of
the prediction period.
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Figure 4
Relative change in population (in % based on preceding year) for males (red) and females (blue) and age groups 50–69 (dashed) and ≥70
years.
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Figure 5
Language-region‒specific age-standardised tobacco-related cancer mortality rates (per 100,000), observed (during 1984–2008) and predicted
(posterior median during 2009–2013 and 2014–2018) for (a) males and (b) females. The vertical line indicates the start of the prediction period.
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Figure 6
Age-standardised tobacco-related cancer mortality rates (per 100,000) for males age ≥50 years, (a) observed during 2004–2008 and predicted
posterior median (b) during 2009–2013 and (c) 2014–2018.
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Figure 7
Age-standardised tobacco-related cancer mortality rates (per 100,000) for females age ≥50years, (a) observed during 2004–2008 and predicted
posterior median (b) during 2009–2013 and (c) 2014–2018.
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